Table 6.
Patient Characteristics of THCA patients in the TCGA datasets
| Characteristic | Low expression of GGCT | High expression of GGCT | p |
|---|---|---|---|
| n | 255 | 255 | |
| T stage, n (%) | 0.004 | ||
| T1 | 82 (16.1%) | 61 (12%) | |
| T2 | 92 (18.1%) | 75 (14.8%) | |
| T3 | 73 (14.4%) | 102 (20.1%) | |
| T4 | 7 (1.4%) | 16 (3.1%) | |
| N stage, n (%) | < 0.001 | ||
| N0 | 134 (29.1%) | 95 (20.7%) | |
| N1 | 87 (18.9%) | 144 (31.3%) | |
| Pathologic stage, n (%) | 0.039 | ||
| Stage I | 149 (29.3%) | 137 (27%) | |
| Stage II | 33 (6.5%) | 19 (3.7%) | |
| Stage III | 49 (9.6%) | 64 (12.6%) | |
| Stage IV | 23 (4.5%) | 34 (6.7%) | |
| Histological type, n (%) | < 0.001 | ||
| Classical | 160 (31.4%) | 204 (40%) | |
| Follicular | 84 (16.5%) | 17 (3.3%) | |
| Other | 4 (0.8%) | 5 (1%) | |
| Tall Cell | 7 (1.4%) | 29 (5.7%) | |
| Extrathyroidal extension, n (%) | < 0.001 | ||
| No | 193 (39.2%) | 145 (29.5%) | |
| Yes | 49 (10%) | 105 (21.3%) | |
| Thyroid gland disorder history, n (%) | 0.003 | ||
| Lymphocytic thyroiditis | 43 (9.5%) | 31 (6.9%) | |
| Nodular hyperplasia | 42 (9.3%) | 26 (5.8%) | |
| Normal | 123 (27.2%) | 162 (35.8%) | |
| Other, specify | 17 (3.8%) | 8 (1.8%) |
TCGA The cancer genome atlas, THCA thyroid cancer